The present invention relates to monoclonal antibodies binding to human angiopoetin-like protein 4 (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.本發明係關於結合至人類血管生成素樣蛋白質4(下文中有時稱為「ANGPTL4」)的單株抗體,以及包含其的醫藥組合物及治療方法。